Journal of Genetic Counseling

, Volume 26, Issue 3, pp 620–627 | Cite as

Knowledge and Self-Esteem of Individuals with Neurofibromatosis Type 1 (NF1)

  • Kayla Rosnau
  • S. Shahrukh Hashmi
  • Hope Northrup
  • John Slopis
  • Sarah Noblin
  • Myla Ashfaq
Original Research

Abstract

Neurofibromatosis Type 1 (NF1) is a progressive genetic disorder characterized by physical findings such as café-au-lait macules, Lisch nodules, and neurofibromas in addition to other medical complications. Learning and social problems are more prevalent among individuals affected with NF1. It has been reported that people with NF1 have lower self-esteem (SE) when compared to the general population. Additionally, a study published over 20 years ago found that overall knowledge of NF1 was lacking in individuals affected with the condition. The goals of our study were to evaluate NF1 knowledge in adolescents and adults with the condition, as well as to determine if there is a link between patient knowledge and SE. Furthermore, we explored the impact of other factors, such as attendance at a NF1 support group and having a family history of NF1, on knowledge and SE. A survey comprised of knowledge-based questions and the Rosenberg Self-Esteem Scale was distributed to individuals with NF1 through the Texas NF Foundation. Overall, the 49 respondents (13 to 73 years of age) had a mean knowledge score of 77.9 % correct answers. Consistent with previous studies, the SE of our study population was lower when compared to general population norms. Although no correlation between knowledge and SE was observed, SE scores were on average higher if a person reported the following: having friends with NF1 (p = 0.009); attending a NF1 support group (p = 0.006); receiving care at a NF clinic (p = 0.049); or having received genetic counseling (p = 0.008). Further research is needed to better understand the relationship between these factors and SE in the NF1 population.

Keywords

Neurofibromatosis Self-esteem Knowledge Education Coping 

Notes

Acknowledgments

This study was completed in partial fulfillment of the requirements for the first author’s Master of Science in genetic counseling from University of Texas Health Science Center at Houston. The authors would like to thank the cooperation and support of the Texas NF Foundation during this study.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human Studies and Informed Consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Animal Studies

No animal studies were carried out by the authors for this article.

Supplementary material

10897_2016_36_MOESM1_ESM.docx (17 kb)
ESM 1 (DOCX 17 kb)

References

  1. Ablon, J. (2012). Social stigma in Neurofibromatosis 1, In Neurofibromatosis Type 1 (pp. 673–682). Berlin Heidelberg: Springer. doi: 10.1007/978-3-642-32864-0_42.CrossRefGoogle Scholar
  2. Ahern, N., Ark, P., & Byers, J. (2008). Resilience and coping strategies in adolescents. Paediatric Nursing, 20(10), 32–26. doi: 10.7748/paed2008.12.20.10.32.c6903.CrossRefPubMedGoogle Scholar
  3. Alexander, J. A., Hearld, L. R., Mittler, J. N., & Harvey, J. (2012). Patient-physician role relationships and patient activation among individuals with chronic illness. Health Services Research, 47(3), 1201–1223. doi: 10.1111/j.1475-6773.2011.01354.x.CrossRefPubMedGoogle Scholar
  4. Barke, J., Harcourt, D., & Coad, J. (2013). ‘It’s like a bag of pick and mix—you don’t know what you are going to get’: young people’s experience of neurofibromatosis type 1. Journal of Advanced Nursing, 70(7), 1594–1603. doi: 10.1111/jan.12319.CrossRefPubMedGoogle Scholar
  5. Benjamin, C. M., Colley, A., Donnai, D., Kingston, H., Harris, R., & Kerzin-Storrar, L. (1993). Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families. Journal of Medical Genetics, 30(7), 567–574.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Crawford, H. A., Barton, B., Wilson, M. J., Berman, Y., McKelvey-Martin, V. J., Morrison, P. J., et al. (2015). The impact of Neurofibromatosis type 1 on the health and wellbeing of Australian adults. Journal of Genetic Counseling. doi: 10.1007/s10897-015-9829-5.PubMedGoogle Scholar
  7. Gaff, C., & Clarke, A. (2007). Stigmatization, culture and counseling a commentary on growing up and living with NF1: a UK–Bangladeshi case study—by Santi Rozario. Journal of Genetic Counseling, 16, 561–565. doi: 10.1007/s10897-007-9098-z.CrossRefPubMedGoogle Scholar
  8. Gray-Little, B., Williams, V. S. L., & Hancock, T. D. (1997). An item response theory analysis of the Rosenberg self-esteem scale. Personality and Social Psychology Bulletin, 23(5), 443–451. doi: 10.1177/0146167297235001.CrossRefGoogle Scholar
  9. Heatherton, T. F., & Wyland, C. (2003). Assessing self-esteem. In Positive psychological assessment: a handbook of models and measures (pp. 219–233). Washington: American Psychological Association.CrossRefGoogle Scholar
  10. Holmbeck, G. N. (2002). A developmental perspective on adolescent health and illness: an introduction to the special issues. Journal of Pediatric Psychology, 27(5), 409–415. doi: 10.1093/jpepsy/27.5.409.CrossRefPubMedGoogle Scholar
  11. Hummelvoll, G., & Antonsen, K. M. (2013). Young adults’ experience of living with Neurofibromatosis type 1. Journal of Genetic Counseling, 22, 188–199. doi: 10.1007/s10897-012-9527-5.CrossRefPubMedGoogle Scholar
  12. Krab, L. C., Oostenbrink, R., de Goede-Bolder, A., Aarsen, F. K., Elgersma, Y., & Moll, H. A. (2009). Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. The Journal of Pediatrics, 154(3), 420-425–425 e421. doi: 10.1016/j.jpeds.2008.08.045.CrossRefGoogle Scholar
  13. Levine, T. M., Materek, A., Abel, J., O'Donnell, M., & Cutting, L. E. (2006). Cognitive profile of neurofibromatosis type 1. Seminars in Pediatric Neurology, 13(1), 8–20. doi: 10.1016/j.spen.2006.01.006.CrossRefPubMedGoogle Scholar
  14. Oates, E. C., Payne, J. M., Foster, S. L., Clarke, N. F., & North, K. N. (2013). Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge. American Journal of Medical Genetics Part A, 161A, 659–666. doi: 10.1002/ajmg.a.35840.CrossRefPubMedGoogle Scholar
  15. Page, P., Page, G., Ecosse, E., Korf, B., Leplege, A., & Wolkenstein, P. (2006). Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases. American Journal of Medical Genetics Part A, 140A, 1893–1898. doi: 10.1002/ajmg.a.31422.CrossRefGoogle Scholar
  16. Plumridge, G., Metcalfe, A., Coad, J., & Gill, P. (2011). The role of support groups in facilitating families in coping with a genetic condition and in discussion of genetic risk information. Health Expectations, 15, 255–266. doi: 10.1111/j.1369-7625.2011.00663.x.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Psychological & Social Implications. (2010). Understanding genetics: A New England guide for patients and health professionals. Needham, MA: Genetic Alliance; New England Public Health Genetics Education Collaborative.Google Scholar
  18. Radke, H. B., Sebold, C. D., Allison, C., Haidle, J. L., & Schneider, G. (2007). Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of genetic counselors. Journal of Genetic Counseling, 16, 387–407. doi: 10.1007/s10897-007-9101-8.CrossRefGoogle Scholar
  19. Resta, R., Biesecker, B., Bennett, R., Blum, S., Estabrooks Hahn, S., Strecker, M., et al. (2006). A new definition of genetic counseling: National Society of genetic counselors’ task force report. Journal of Genetic Counseling, 15(2), 77–83. doi: 10.1007/s10897-005-9014-3.CrossRefPubMedGoogle Scholar
  20. Robins, R. W., Hendin, H. M., & Trzesniewski, K. H. (2001). Measuring global self-esteem: construct validation of a single-item measure and the Rosenberg self-esteem scale. Personality and Social Psychology Bulletin, 27(2), 151–161. doi: 10.1177/0146167201272002.CrossRefGoogle Scholar
  21. Rosenberg, M. (1989). Society and the adolescent self-image. Revised edition. Middletown, Connecticut: Wesleyan University Press.Google Scholar
  22. Sinclair, S., Blais, M., Gansler, D., Sandberg, E., Bistis, K., & Locicero, A. (2010). Psychometric properties of the Rosenberg self-esteem scale: overall and across demographic groups living within the United States. Evaluation & the Health Professions, 31, 56–80. doi: 10.1177/0163278709356187.CrossRefGoogle Scholar
  23. Smith, K. B., Wang, D. L., Plotkin, S. R., & Park, E. R. (2013). Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness. Psycho-Oncology, 22, 2711–2719. doi: 10.1002/pon.3350.CrossRefPubMedGoogle Scholar
  24. Wang, D., Smith, K., Esparza, S., Leigh, F., Muzikansky, A., Park, E., et al. (2012). Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome. Genetics in Medicine, 14(12), 977–982. doi: 10.1038/gim.2012.85.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009). Neurofibromatosis type 1 revisited. Pediatrics, 123(1), 124–133. doi: 10.1542/peds.2007-3204.CrossRefPubMedGoogle Scholar
  26. Wolkenstein, P., Zeller, J., Revus, J., Ecosse, E., & Leplege, A. (2001). Quality-of-life impairment in Neurofibromatosis type 1. Archives of Dermatology, 137, 1421–1425. doi: 10.1038/gim.2012.85.CrossRefPubMedGoogle Scholar
  27. Zoller, M., Rembeck, B., Akesson, H. O., & Angervall, L. (1995). Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Dermato-Venereologica, 75(2), 136–140.PubMedGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2016

Authors and Affiliations

  • Kayla Rosnau
    • 1
    • 2
  • S. Shahrukh Hashmi
    • 1
    • 3
  • Hope Northrup
    • 1
    • 4
  • John Slopis
    • 5
    • 6
  • Sarah Noblin
    • 1
    • 7
  • Myla Ashfaq
    • 1
    • 4
  1. 1.The University of Texas Graduate School of Biomedical SciencesHoustonUSA
  2. 2.Clinical Cancer Genetics ProgramThe University of Texas MD Anderson Cancer CenterHoustonUSA
  3. 3.Pediatrics Research Center, Department of PediatricsMcGovern Medical School at UTHealthHoustonUSA
  4. 4.Division of Medical Genetics, Department of PediatricsMcGovern Medical School at UTHealthHoustonUSA
  5. 5.Department of NeurologyMcGovern Medical School at UTHealthHoustonUSA
  6. 6.Department of Neuro-Oncology, Division of Cancer MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA
  7. 7.Department of Obstetrics, Gynecology, & Reproductive SciencesMcGovern Medical School at UTHealthHoustonUSA

Personalised recommendations